Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes: Renal benefits of lowering BP in the absence of hypertension.

Literature DB >> 19556992

Diabetes: Renal benefits of lowering BP in the absence of hypertension.

Abstract

Regardless of baseline blood pressure, treatment with a combination of an angiotensin-converting enzyme inhibitor and a diuretic decreases incidence of renal events in patients with type 2 diabetes. The combination therapy approach could be the key to achieving renoprotection.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19556992 DOI： 10.1038/nrneph.2009.92

Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314

Keyword Cloud
References

10 in total

Review 1. The case for using albuminuria in staging chronic kidney disease.

Authors: Ron T Gansevoort; Paul E de Jong
Journal: J Am Soc Nephrol Date: 2009-03 Impact factor: 10.121

2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors:
Journal: Lancet Date: 2000-01-22 Impact factor: 79.321

3. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.

Authors: Marc A Pohl; Samuel Blumenthal; Daniel J Cordonnier; Fernando De Alvaro; Giacomo Deferrari; Gilbert Eisner; Enric Esmatjes; Richard E Gilbert; Lawrence G Hunsicker; Jose B Lopes de Faria; Ruggero Mangili; Jack Moore; Efrain Reisin; Eberhard Ritz; Guntram Schernthaner; Samuel Spitalewitz; Hilary Tindall; Roger A Rodby; Edmund J Lewis
Journal: J Am Soc Nephrol Date: 2005-08-24 Impact factor: 10.121

4. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors: Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal: Lancet Date: 2007-09-08 Impact factor: 79.321

5. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.

Authors: Michel Marre; Juan Garcia Puig; Franciszek Kokot; Margarita Fernandez; György Jermendy; Lionel Opie; Valentin Moyseev; André Scheen; Constantin Ionescu-Tirgoviste; M Helena Saldanha; Aaron Halabe; Bryan Williams; Decio Mion Júnior; Maximino Ruiz; Kjeld Hermansen; Jaakko Tuomilehto; Bartolomé Finizola; Yves Gallois; Philippe Amouyel; Jean-Pierre Ollivier; Roland Asmar
Journal: J Hypertens Date: 2004-08 Impact factor: 4.844

6. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.

Authors: Peter Gaede; Lise Tarnow; Pernille Vedel; Hans-Henrik Parving; Oluf Pedersen
Journal: Nephrol Dial Transplant Date: 2004-08-24 Impact factor: 5.992

7. Lowering blood pressure reduces renal events in type 2 diabetes.

Authors: Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal: J Am Soc Nephrol Date: 2009-02-18 Impact factor: 10.121